Yi Q - Search Results

1

Effects of ramipril on coronary events in high-risk persons: results of the Heart Outcomes Prevention Evaluation Study.

Dagenais GR, Yusuf S, Bourassa MG, Yi Q, Bosch J, Lonn EM, Kouz S, Grover J; HOPE Investigators. Dagenais GR, et al. Among authors: yi q. Circulation. 2001 Jul 31;104(5):522-6. doi: 10.1161/hc3001.093502. Circulation. 2001. PMID: 11479247 Clinical Trial.

2

Effects of ramipril and vitamin E on atherosclerosis: the study to evaluate carotid ultrasound changes in patients treated with ramipril and vitamin E (SECURE).

Lonn E, Yusuf S, Dzavik V, Doris C, Yi Q, Smith S, Moore-Cox A, Bosch J, Riley W, Teo K; SECURE Investigators. Lonn E, et al. Among authors: yi q. Circulation. 2001 Feb 20;103(7):919-25. doi: 10.1161/01.cir.103.7.919. Circulation. 2001. PMID: 11181464 Clinical Trial.

3

Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals.

Gerstein HC, Mann JF, Yi Q, Zinman B, Dinneen SF, Hoogwerf B, Hallé JP, Young J, Rashkow A, Joyce C, Nawaz S, Yusuf S; HOPE Study Investigators. Gerstein HC, et al. Among authors: yi q. JAMA. 2001 Jul 25;286(4):421-6. doi: 10.1001/jama.286.4.421. JAMA. 2001. PMID: 11466120

4

Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril.

Mathew J, Sleight P, Lonn E, Johnstone D, Pogue J, Yi Q, Bosch J, Sussex B, Probstfield J, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Investigators. Mathew J, et al. Among authors: yi q. Circulation. 2001 Oct 2;104(14):1615-21. doi: 10.1161/hc3901.096700. Circulation. 2001. PMID: 11581138 Clinical Trial.

5

Risk factors, atherosclerosis, and cardiovascular disease among Aboriginal people in Canada: the Study of Health Assessment and Risk Evaluation in Aboriginal Peoples (SHARE-AP).

Anand SS, Yusuf S, Jacobs R, Davis AD, Yi Q, Gerstein H, Montague PA, Lonn E. Anand SS, et al. Among authors: yi q. Lancet. 2001 Oct 6;358(9288):1147-53. doi: 10.1016/s0140-6736(01)06255-9. Lancet. 2001. PMID: 11597669

6

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.

Eikelboom JW, Hirsh J, Weitz JI, Johnston M, Yi Q, Yusuf S. Eikelboom JW, et al. Among authors: yi q. Circulation. 2002 Apr 9;105(14):1650-5. doi: 10.1161/01.cir.0000013777.21160.07. Circulation. 2002. PMID: 11940542

7

Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects.

Gupta M, Doobay AV, Singh N, Anand SS, Raja F, Mawji F, Kho J, Karavetian A, Yi Q, Yusuf S. Gupta M, et al. Among authors: yi q. CMAJ. 2002 Mar 19;166(6):717-22. CMAJ. 2002. PMID: 11944758 Free PMC article.

8

Effect of long-term therapy with ramipril in high-risk women.

Lonn E, Roccaforte R, Yi Q, Dagenais G, Sleight P, Bosch J, Suhan P, Micks M, Probstfield J, Bernstein V, Yusuf S; HOPE Investigators. Heart Outcomes Prevention Evaluation. Lonn E, et al. Among authors: yi q. J Am Coll Cardiol. 2002 Aug 21;40(4):693-702. doi: 10.1016/s0735-1097(02)02035-1. J Am Coll Cardiol. 2002. PMID: 12204499 Free article. Clinical Trial.

9

Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy.

Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, Gerstein HC; HOPE Study; MICRO-HOPE Study. Lonn E, et al. Among authors: yi q. Diabetes Care. 2002 Nov;25(11):1919-27. doi: 10.2337/diacare.25.11.1919. Diabetes Care. 2002. PMID: 12401733 Clinical Trial.

10

Relationship of anti-60 kDa heat shock protein and anti-cholesterol antibodies to cardiovascular events.

Veres A, Füst G, Smieja M, McQueen M, Horváth A, Yi Q, Bíró A, Pogue J, Romics L, Karádi I, Singh M, Gnarpe J, Prohászka Z, Yusuf S; Heart Outcomes Prevention Evaluation (HOPE) Study Investigators. Veres A, et al. Among authors: yi q. Circulation. 2002 Nov 26;106(22):2775-80. doi: 10.1161/01.cir.0000038890.39298.8d. Circulation. 2002. PMID: 12451002

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,574 results

Search Page